Julie Smith's Net Worth

$1.64 Million

Estimate Recalculated Dec 11, 2024 12:01AM EST

Who is Julie Smith

Julie Smith has an estimated net worth of $1.64 Million. This is based on reported shares across multiple companies, which include EXELIXIS, INC., Stoke Therapeutics, Inc., Audentes Therapeutics, Inc., and Raptor Pharmaceutical Corp.

SEC CIK

Julie Smith's CIK is 0001557928

Past Insider Trading and Trends

2016 was Julie Smith's most active year for acquiring shares with 4 total transactions. Julie Smith's most active month to acquire stocks was the month of April. 2016 was Julie Smith's most active year for disposing of shares, totalling 5 transactions. Julie Smith's most active month to dispose stocks was the month of September. 2014 saw Julie Smith paying a total of $199,996.50 for 320,015 shares, this is the most they've acquired in one year. In 2016 Julie Smith cashed out on 677,583 shares for a total of $989,442.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EXELIXIS, INC.

Investor
Updated Aug 15, 2024
Form 4
-30.28%
-4.68K
Aug 15, 2024
10.78K
Disposition
Aug 13
Form 4
551.79%
30.05K
Jun 04, 2024
35.49K
Grant
May 31
Form 4
-83.36%
-27.28K
$21.12
-$576.15K
May 23, 2024
5.45K
Sale
May 21
Form 4
44.09K
Jun 02, 2023
44.09K
Grant
Jun 01
Form 4
42.42K
May 27, 2022
42.42K
Grant
May 26
Form 4
100.75%
16.42K
May 28, 2021
32.73K
Grant
May 27
Form 4
2,036.44%
15.54K
May 22, 2020
16.30K
Grant
May 21
Form 4
42.64K
May 24, 2019
42.64K
Grant
May 23
Form 4
31.17K
May 24, 2018
31.17K
Grant
May 24
Form 4
23.49K
May 26, 2017
23.49K
Grant
May 25
Form 4
16.62K
Feb 24, 2017
16.62K
Grant
Feb 23
Form 4
26.76K
Sep 26, 2016
26.76K
Grant
Sep 22
Form 3
Sep 26, 2016
Showing 13 results

Stoke Therapeutics, Inc.

Investor
Updated Jun 07, 2024
Form 4
7.64K
Jun 07, 2024
7.64K
Grant
Jun 05
Form 4
19.44K
Jun 15, 2023
19.44K
Grant
Jun 13
Form 4
21.00K
Jun 08, 2022
21.00K
Grant
Jun 07
Form 4
11.65K
Jun 25, 2021
11.65K
Grant
Jun 08
Form 4
29.55K
Jun 05, 2020
29.56K
Grant
Jun 03
Form 3
Jun 05, 2020
Showing 6 results

Audentes Therapeutics, Inc.

Investor
Updated Jan 15, 2020
Form 4
-100.00%
-53.20K
Jan 15, 2020
Disposition
Jan 15
Form 4
16.20K
Feb 08, 2019
16.20K
Grant
Feb 06
Form 4
10.00K
Jun 08, 2018
10.00K
Grant
Jun 08
Form 4
9.00K
Oct 10, 2017
9.00K
Grant
Oct 08
Form 4
18.00K
Jan 05, 2017
18.00K
Grant
Jan 01
Form 3
Dec 13, 2016
Showing 6 results

Raptor Pharmaceutical Corp

President and CEO
Updated Oct 26, 2016
Form 4
-100.00%
-677.58K
$9.00
-$989.44K
Oct 26, 2016
Disposition
Oct 24 - Oct 25
Form 4
803.09%
304.77K
Feb 11, 2016
342.72K
Grant
Feb 09
Form 4
350.00K
Jan 20, 2015
350.00K
Grant
Jan 15
Form 4
$5.27
$200.00K
Dec 05, 2014
190.00K
Options
Dec 03
Form 4
175.00K
Jul 31, 2014
175.00K
Grant
Jul 29
Form 4
107.06K
Feb 11, 2014
107.07K
Grant
Feb 07
Form 4
190.00K
Sep 12, 2012
190.00K
Grant
Sep 10
Form 3
Sep 12, 2012
Showing 8 results